Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Terminated Initiated Jun 26, 2012 (14 years ago)

Vecuronium Bromide for Injection

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Presence of Particulate Matter

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Vecuronium Bromide for Injection, For IV use only, 20 mg per vial, 10 x 10 mg Vials, lyophilized powder per carton, Rx Only, Mfr. By: Ben Venue Laboratories, Bedford, OH 44146: Mfg for: Bedford Labs, Bedford, OH 44146, NDC 55390-039-10.

Affected NDC 55390-0039-10

Compare with the code on your package — it is the most precise check available.

Drug: Vecuronium

Recalling firm
Ben Venue Laboratories Inc
NDC code
55390-039-10
Origin
OH, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1697-2012 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Vecuronium recalls

See all
Class II · Moderate risk

vecuronium

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc D-1048-2023
Class II · Moderate risk

Vecuronium Bromide for Injection

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Terminated Sterility / contamination Teva Pharmaceuticals USA NDC 0703-2914-01 D-0279-2021

Other recalls by Ben Venue Laboratories Inc

All 2012 recalls
Class II · Moderate risk

CYTARAbine for Injection USP

Lack of Assurance of Sterility: Crimp defects during visual inspection could affect container closure integrity.

Terminated Sterility / contamination Ben Venue Laboratories Inc NDC 55390-808-01 D-1543-2014
Class I · High risk

Acetylcysteine Solution

Presence of Particulate Matter: During a review of retain samples, the firm found a glass particulate in one lot of Acetylcysteine Solution

Terminated Particulate / foreign matter Ben Venue Laboratories Inc NDC 0054-3025-02 D-1326-2014
Class II · Moderate risk

Octreotide Acetate Injection

Short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.

Terminated Failed specification Ben Venue Laboratories Inc NDC 55390-160-10 D-1377-2012